2024 Q4 Form 10-Q Financial Statement

#000149315224045798 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $2.500K
YoY Change -83.33%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $110.7K
YoY Change 611.9%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $117.9K $110.7K
YoY Change 6.53% 611.9%
Operating Profit -$117.9K -$108.2K
YoY Change 9.03%
Interest Expense $2.800K
YoY Change -391.67%
% of Operating Profit
Other Income/Expense, Net $2.824K
YoY Change
Pretax Income -$105.3K
YoY Change 6873.51%
Income Tax
% Of Pretax Income
Net Earnings -$117.9K -$105.3K
YoY Change 12.0% 6873.51%
Net Earnings / Revenue -4212.0%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 154.3M shares 154.3M shares 26.92M shares
Diluted Shares Outstanding 154.3M shares 26.92M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change -100.0%
Cash & Equivalents $13.67K $2.00
Short-Term Investments
Other Short-Term Assets $1.100K
YoY Change -78.35%
Inventory
Prepaid Expenses $1.095K $1.095K
Receivables
Other Receivables $0.00
Total Short-Term Assets $14.76K $1.097K
YoY Change 1245.85% -93.1%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $0.00 $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $14.76K $1.097K
Total Long-Term Assets $0.00 $0.00
Total Assets $14.76K $1.097K
YoY Change 1245.85% -93.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $83.44K $29.08K
YoY Change 186.94%
Accrued Expenses $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $91.55K $29.08K
YoY Change 214.82% -71.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $91.55K $29.08K
Total Long-Term Liabilities $0.00
Total Liabilities $91.55K $29.08K
YoY Change 214.82% -71.67%
SHAREHOLDERS EQUITY
Retained Earnings -$2.789M -$1.527M
YoY Change 82.64% 8.23%
Common Stock $154.3K $28.58K
YoY Change 439.97% 6.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$76.79K -$27.98K
YoY Change
Total Liabilities & Shareholders Equity $14.76K $1.097K
YoY Change 1245.85% -93.34%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$117.9K -$105.3K
YoY Change 12.0% 6873.51%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$900.00
YoY Change -47.98%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -900.0
Cash From Investing Activities
Cash From Financing Activities 0.000
Net Change In Cash -900.0
YoY Change -47.98%
FREE CASH FLOW
Cash From Operating Activities -$900.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001473490
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-4170100
dei Entity Address Address Line1
EntityAddressAddressLine1
110 Front Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
Jupiter
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33477
dei City Area Code
CityAreaCode
(561)
dei Local Phone Number
LocalPhoneNumber
240-0333
dei Security12b Title
Security12bTitle
Common Stock par value $0.001
dei Trading Symbol
TradingSymbol
GLAI
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1095 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
14764 usd
CY2024Q3 us-gaap Assets
Assets
14764 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
83441 usd
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
8109 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
91550 usd
CY2024Q3 us-gaap Liabilities
Liabilities
91550 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2558286 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-76786 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14764 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-76786 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
dei Document Type
DocumentType
10-Q
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
154312024 shares
CY2023Q4 us-gaap Cash
Cash
183964 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1095 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
185059 usd
CY2023Q4 us-gaap Assets
Assets
185059 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
232089 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
5100 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
237189 usd
CY2023Q4 us-gaap Liabilities
Liabilities
237189 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154312024 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154312024 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
154312 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
154312 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1844951 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-52130 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
185059 usd
CY2023Q3 GLAI Contracted Services Related Party
ContractedServicesRelatedParty
2500 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2500 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
82511 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
106875 usd
us-gaap Professional Fees
ProfessionalFees
416717 usd
us-gaap Professional Fees
ProfessionalFees
129868 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
117932 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
110660 usd
us-gaap Operating Expenses
OperatingExpenses
737991 usd
us-gaap Operating Expenses
OperatingExpenses
145405 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-117932 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-108160 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-737991 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-111405 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-117932 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-105336 usd
us-gaap Net Income Loss
NetIncomeLoss
-737991 usd
us-gaap Net Income Loss
NetIncomeLoss
-113298 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154312024 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154312024 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26922006 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26922006 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
154312024 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
154312024 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26922006 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26922006 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-88970 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2012 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-90982 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5949 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-96931 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 GLAI Contracted Services Related Party
ContractedServicesRelatedParty
usd
GLAI Contracted Services Related Party
ContractedServicesRelatedParty
usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-163439
dei Entity Registrant Name
EntityRegistrantName
Global AI, Inc.
CY2024Q3 us-gaap Cash
Cash
13669 usd
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154312024 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154312024 shares
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2789384 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2051393 usd
GLAI Contracted Services Related Party
ContractedServicesRelatedParty
34000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35421 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3785 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
321274 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15537 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
-2824 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1893 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2824 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1893 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-105336 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-202267 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-52130 usd
CY2024Q1 GLAI Adjustments To Additional Paid In Capital Cash Received From Subscription Receivable
AdjustmentsToAdditionalPaidInCapitalCashReceivedFromSubscriptionReceivable
200000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-346210 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-198340 usd
CY2024Q2 GLAI Adjustments To Additional Paid In Capital Cash Received From Subscription Receivable
AdjustmentsToAdditionalPaidInCapitalCashReceivedFromSubscriptionReceivable
373336 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-273849 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-98853 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-98853 usd
CY2024Q3 GLAI Adjustments To Additional Paid In Capital Cash Received From Subscription Receivable
AdjustmentsToAdditionalPaidInCapitalCashReceivedFromSubscriptionReceivable
140000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-117932 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-76786 usd
us-gaap Net Income Loss
NetIncomeLoss
-737991 usd
us-gaap Net Income Loss
NetIncomeLoss
-113298 usd
us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-5000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-753 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-148648 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
27780 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3009 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-9472 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-883630 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-89237 usd
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
94120 usd
GLAI Proceeds From Funds Received From Subscription Receivable
ProceedsFromFundsReceivedFromSubscriptionReceivable
713335 usd
GLAI Proceeds From Funds Received From Subscription Receivable
ProceedsFromFundsReceivedFromSubscriptionReceivable
174285 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
713335 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
80165 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-170295 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9072 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
183964 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9074 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13669 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zWYAbC8aJtT7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The financial statements are prepared in accordance with Accounting Principles Generally Accepted in the United States (“GAAP”). These accounting principles require the Company to make certain estimates, judgments and assumptions. The Company believes that the estimates, judgments and assumptions upon which it relies are reasonable based upon information available at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. The financial statements would be affected to the extent there are material differences between these estimates and actual results. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its application. There are also areas in which management’s judgment in selecting any available alternative would not produce a materially different result. Significant estimates include the valuation allowance on deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Net Income Loss
NetIncomeLoss
-737991 usd
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
883630 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-76786 usd
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154312024 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
154312024 shares
CY2024Q1 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
4-for-1 forward stock split
CY2024Q3 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
0 integer

Files In Submission

Name View Source Status
0001493152-24-045798-index-headers.html Edgar Link pending
0001493152-24-045798-index.html Edgar Link pending
0001493152-24-045798.txt Edgar Link pending
0001493152-24-045798-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
glai-20240930.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
glai-20240930_cal.xml Edgar Link unprocessable
glai-20240930_def.xml Edgar Link unprocessable
glai-20240930_lab.xml Edgar Link unprocessable
glai-20240930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending